Morgan Stanley Maintains Overweight on Dow Chemical (DOW)

Morgan Stanley is out with its report today on Dow Chemical DOW, maintaining Overweight. In a note to clients, Morgan Stanley writes, "We continue to rate Dow Chemical Overweight, based on our long-term positive view on the petrochemical supercycle, the recent underperformance of LYB LYB has created a large relative value differential between the two stocks, despite similar macro exposure. Over the next 60 days, we believe LYB will outperform DOW." At the time of posting, shares of DOW were trading pre-market at $37.65, down 0.16% from Monday's close.